Blood group A epitopes do not facilitate entry of SARS-CoV-2
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:290 |
---|---|
Enthalten in: |
Journal of internal medicine - 290(2021), 1 vom: 27. Juli, Seite 223-226 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Schetelig, J [VerfasserIn] |
---|
Links: |
---|
Themen: |
ABO Blood-Group System |
---|
Anmerkungen: |
Date Completed 08.07.2021 Date Revised 08.07.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/joim.13256 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM320634701 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM320634701 | ||
003 | DE-627 | ||
005 | 20231225174011.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/joim.13256 |2 doi | |
028 | 5 | 2 | |a pubmed24n1068.xml |
035 | |a (DE-627)NLM320634701 | ||
035 | |a (NLM)33501658 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Schetelig, J |e verfasserin |4 aut | |
245 | 1 | 0 | |a Blood group A epitopes do not facilitate entry of SARS-CoV-2 |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.07.2021 | ||
500 | |a Date Revised 08.07.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a ABO blood groups | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a blood group A1 | |
650 | 4 | |a blood group A2 | |
650 | 7 | |a ABO Blood-Group System |2 NLM | |
650 | 7 | |a Epitopes |2 NLM | |
700 | 1 | |a Baldauf, H |e verfasserin |4 aut | |
700 | 1 | |a Wendler, S |e verfasserin |4 aut | |
700 | 1 | |a Heidenreich, F |e verfasserin |4 aut | |
700 | 1 | |a Real, R |e verfasserin |4 aut | |
700 | 1 | |a Kolditz, M |e verfasserin |4 aut | |
700 | 1 | |a Rosner, A |e verfasserin |4 aut | |
700 | 1 | |a Dalpke, A |e verfasserin |4 aut | |
700 | 1 | |a de With, K |e verfasserin |4 aut | |
700 | 1 | |a Lange, V |e verfasserin |4 aut | |
700 | 1 | |a Markert, J |e verfasserin |4 aut | |
700 | 1 | |a Barth, R |e verfasserin |4 aut | |
700 | 1 | |a Bunzel, C |e verfasserin |4 aut | |
700 | 1 | |a Endert, D |e verfasserin |4 aut | |
700 | 1 | |a Hofmann, J A |e verfasserin |4 aut | |
700 | 1 | |a Sauter, J |e verfasserin |4 aut | |
700 | 1 | |a Bernas, S N |e verfasserin |4 aut | |
700 | 1 | |a Schmidt, A H |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of internal medicine |d 1992 |g 290(2021), 1 vom: 27. Juli, Seite 223-226 |w (DE-627)NLM012608750 |x 1365-2796 |7 nnns |
773 | 1 | 8 | |g volume:290 |g year:2021 |g number:1 |g day:27 |g month:07 |g pages:223-226 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/joim.13256 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 290 |j 2021 |e 1 |b 27 |c 07 |h 223-226 |